Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model

被引:22
作者
Ardavin, C
Luthi, F
Andersson, M
Scarpellino, L
Martin, P
Diggelmann, H
AchaOrbea, H
机构
[1] UNIV LAUSANNE,LUDWIG INST CANC RES,LAUSANNE BRANCH,CH-1066 EPALINGES,SWITZERLAND
[2] UNIV LAUSANNE,INST BIOCHEM,CH-1066 EPALINGES,SWITZERLAND
[3] UNIV COMPLUTENSE MADRID,FAC BIOL,DEPT CELL BIOL,E-28040 MADRID,SPAIN
[4] UNIV LAUSANNE HOSP,INST MICROBIOL,CH-1011 LAUSANNE,SWITZERLAND
[5] UNIV LAUSANNE,INST BIOCHEM,CH-1066 EPALINGES,SWITZERLAND
关键词
D O I
10.1128/JVI.71.10.7295-7299.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mouse mammary tumor virus (MMTV) infects B lymphocytes and expresses a superantigen on the cell surface after integration of its reverse-transcribed genome. Superantigen-dependent B-and T-cell activation becomes detectable 2 to 3 days after infection. We show here that before this event, B cells undergo a polyclonal activation which does not involve massive proliferation, This first phase of B-cell activation is T cell independent. Moreover, during the first phase of activation, when only a small fraction of B cells is infected by MMTV(SW), viral DNA is detected only in activated B cells. Such a B-cell activation is also seen after injection of murine leukemia virus but not after injection of vaccinia virus, despite the very similar kinetics and intensity of the immune response. Since retroviruses require activated target cells to induce efficient infection, these data suggest that the early polyclonal retrovirus-induced target cell activation might play an important role in the establishment of retroviral infections.
引用
收藏
页码:7295 / 7299
页数:5
相关论文
共 32 条
  • [11] TRANSGENIC MOUSE MAMMARY-TUMOR VIRUS SUPERANTIGEN EXPRESSION PREVENTS VIRAL-INFECTION
    GOLOVKINA, TV
    CHERVONSKY, A
    DUDLEY, JP
    ROSS, SR
    [J]. CELL, 1992, 69 (04) : 637 - 645
  • [12] SUPERANTIGEN-REACTIVE CD4+ T-CELLS ARE REQUIRED TO STIMULATE B-CELLS AFTER INFECTION WITH MOUSE MAMMARY-TUMOR VIRUS
    HELD, W
    SHAKHOV, AN
    IZUI, S
    WAANDERS, GA
    SCARPELLINO, L
    MACDONALD, HR
    ACHAORBEA, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 359 - 366
  • [13] AN EXOGENOUS MOUSE MAMMARY-TUMOR VIRUS WITH PROPERTIES OF MLS-1A (MTV-7)
    HELD, W
    SHAKHOV, AN
    WAANDERS, G
    SCARPELLINO, L
    LUETHY, R
    KRAEHENBUHL, JP
    MACDONALD, HR
    ACHAORBEA, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) : 1623 - 1633
  • [14] SUPERANTIGEN-INDUCED IMMUNE STIMULATION AMPLIFIES MOUSE MAMMARY-TUMOR VIRUS-INFECTION AND ALLOWS VIRUS TRANSMISSION
    HELD, W
    WAANDERS, GA
    SHAKHOV, AN
    SCARPELLINO, L
    ACHAORBEA, H
    MACDONALD, HR
    [J]. CELL, 1993, 74 (03) : 529 - 540
  • [15] MHC CLASS-II HIERARCHY OF SUPERANTIGEN PRESENTATION PREDICTS EFFICIENCY OF INFECTION WITH MOUSE MAMMARY-TUMOR VIRUS
    HELD, W
    WAANDERS, GA
    MACDONALD, HR
    ACHAORBEA, H
    [J]. INTERNATIONAL IMMUNOLOGY, 1994, 6 (09) : 1403 - 1407
  • [16] REVERSE TRANSCRIPTASE-DEPENDENT AND TRANSCRIPTASE-INDEPENDENT PHASES OF INFECTION WITH MOUSE MAMMARY-TUMOR VIRUS - IMPLICATIONS FOR SUPERANTIGEN FUNCTION
    HELD, W
    WAANDERS, GA
    ACHAORBEA, H
    MACDONALD, HR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) : 2347 - 2351
  • [17] In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen
    Krummenacher, C
    Diggelmann, H
    AchaOrbea, H
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (05) : 3026 - 3031
  • [18] LAWSON DAT, 1985, J IMMUNOL, V134, P3007
  • [19] POSITIVE SELECTION DETERMINES T-CELL RECEPTOR V-BETA-14 GENE USAGE BY CD8+ T-CELLS
    LIAO, NS
    MALTZMAN, J
    RAULET, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) : 135 - 143
  • [20] A RAPID AND SIMPLE METHOD FOR MEASURING THYMOCYTE APOPTOSIS BY PROPIDIUM IODIDE STAINING AND FLOW-CYTOMETRY
    NICOLETTI, I
    MIGLIORATI, G
    PAGLIACCI, MC
    GRIGNANI, F
    RICCARDI, C
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 139 (02) : 271 - 279